Lyra Therapeutics
LYRA
#9896
Rank
NZ$20.85 M
Marketcap
$0.32
Share price
5.88%
Change (1 day)
-95.79%
Change (1 year)

Lyra Therapeutics (LYRA) - Cash on Hand

Cash on Hand as of September 2024 : NZ$91.38 Million

According to Lyra Therapeutics's latest financial reports the company has NZ$91.38 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lyra Therapeutics - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31NZ$0.15 B130.22%
2021-12-31NZ$66.97 M-35.21%
2020-12-31NZ$0.10 B609.87%
2019-12-31NZ$14.56 M-59.11%
2018-12-31NZ$35.61 M